Call Options Transactions Made in Q4 2024 in Arcus Biosciences, Inc. (RCUS)
This table provides information about the institutional ownership of Arcus Biosciences, Inc. (RCUS) during Q4 2024. The information is specifically focused on institutions that hold call options of Arcus Biosciences, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 12, 2025
Q4 2024
|
Citigroup Inc
|
BUY
|
CALL |
29.9KNew |
$427K - $551K
|
29.9K
$304K
|
|
|
Feb 14, 2025
Q4 2024
|
Ikarian Capital, LLC
Dallas, TX |
BUY
|
CALL |
27.3K+ 24.01% |
$390K - $503K
|
141K
$1.43M
|
|
|
Feb 14, 2025
Q4 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
CALL |
23.6K+ 150.32% |
$337K - $435K
|
39.3K
$399K
|
|
|
Feb 14, 2025
Q4 2024
|
Boothbay Fund Management, LLC
New York, NY |
BUY
|
CALL |
7.9K+ 23.8% |
$113K - $146K
|
41.1K
$418K
|
|
|
Feb 14, 2025
Q4 2024
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
CALL |
-6.7K- 15.3% |
$95.7K - $124K
|
37.1K
$377K
|